PENN MEDICINE CO-INVESTMENT PROGRAM
Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
PENN MEDICINE CO-INVESTMENT PROGRAM
Industry:
Biopharma Biotechnology Health Care Life Science
Status:
Active
Similar Organizations
Accelerate@Babraham
Accelerate@Babraham is the incubation programme of the Babraham Research Campus.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Molecular Forecaster
Molecular Forecaster builds software for drug discovery, metabolism prediction, library design & small molecule asymmetric catalyst design.
Recognify Life Sciences
Recognify Life Sciences is an entity developing a treatment for Cognitive Impairment associated with Schizophrenia ("CIAS").
Reliance Life Sciences
Reliance Life Sciences is a diverse and integrated biotechnology initiative of the Reliance Group of companies
Sharp Corp
Sharp Corp provides contract packaging services for Rx, biotechnology, OTC/nutritional, clinical packaging, animal health.
Global Health Investment Fund (GHIF)
Impact investment fund established to finance late-stage development of new drugs, vaccines and diagnostics for public health challenges
Tricol Biomedical Inc
Tricol Biomedical develops advanced wound care, hemorrhage, infection control & wound management technologies.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Vittoria Biotherapeutics | Penn Medicine Co-Investment Program investment in Seed Round - Vittoria Biotherapeutics | 10 M USD |
| 2021-11-30 | CareAlign | Penn Medicine Co-Investment Program investment in Seed Round - CareAlign | 2.3 M USD |
| 2021-05-18 | Interius BioTherapeutics | Penn Medicine Co-Investment Program investment in Series A - Interius BioTherapeutics | 76 M USD |
| 2021-03-01 | Carisma Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Carisma Therapeutics | 12 M USD |
| 2020-03-13 | Interius BioTherapeutics | Penn Medicine Co-Investment Program investment in Venture Round - Interius BioTherapeutics | 5.5 M USD |
| 2019-10-31 | Tmunity Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Tmunity Therapeutics | 75 M USD |
| 2019-09-17 | Linnaeus Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Linnaeus Therapeutics | 12 M USD |
| 2019-01-03 | Cabaletta Bio | Penn Medicine Co-Investment Program investment in Series B - Cabaletta Bio | 50 M USD |
| 2018-09-07 | Linnaeus Therapeutics | Penn Medicine Co-Investment Program investment in Series A - Linnaeus Therapeutics | 4.4 M USD |
| 2018-06-27 | Carisma Therapeutics | Penn Medicine Co-Investment Program investment in Series A - Carisma Therapeutics | 53 M USD |